Merck
MRK
#47
Rank
HK$2.538 T
Marketcap
HK$1,028
Share price
0.45%
Change (1 day)
54.57%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): HK$27.84

According to Merck's latest financial reports the company's current EPS (TTM) is HK$28.03. In 2025 the company made an earnings per share (EPS) of HK$57.32 an increase over its 2024 EPS that were of HK$53.00.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.84-51.43%
2025HK$57.328.15%
2024HK$53.004308.46%
2023HK$1.20-97.32%
2022HK$44.9310.92%
2021HK$40.5184.68%
2020HK$21.93-27.2%
2019HK$30.1363.44%
2018HK$18.43151.11%
2017HK$7.34-54.58%
2016HK$16.1630.21%
2015HK$12.41-61.99%
2014HK$32.65180.51%
2013HK$11.64-31.82%
2012HK$17.076.62%
2011HK$16.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.49 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.05 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.30 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.33 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.54 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.07-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$27.92-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.47 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$10.74-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel